Abstract
TEN years ago, in September 1977, the National Institutes of Health (NIH) launched its Consensus Development Program by convening a conference on screening for breast cancer.1 This effort initiated a decade of increasing interest in technology assessment in health care, not only in this country but also abroad. In the mid 1970s, there was mounting concern in Congress over extraordinary increases in national health care expenditures. There was a general perception that these increases were at least partly due to the premature application of expensive technical innovations in medicine before their safety, efficacy, and costs had been adequately evaluated. Several . . .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
